Condition
Intraductal Papillary Mucinous Neoplasm clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Intraductal Papillary Mucinous Neoplasm clinical trials that are recruiting, at sites in 6 countries (most in China (4), United States (2), Italy (2)). 1 was first registered in the last 30 days. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1New in 30 days
- 6Countries
Newest Intraductal Papillary Mucinous Neoplasm clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Blood protein biomarkers to help diagnose pancreatic cancer in adults | — | Iași | Recruiting | Oct 15, 2026 |
| Liquid biopsy biomarkers to detect and monitor pancreatic cancer | — | Milan, MI | Recruiting | Jul 14, 2026 |
| Why surgery was performed for IPMN and the outcomes | — | Phoenix, Arizona and 13 other locations | Recruiting | Oct 14, 2025 |
| AI-enhanced low-dose CT to screen for pancreatic cancer | — | Shanghai, Shanghai Municipality and 4 other locations | Recruiting | Aug 12, 2025 |
| AI-based early detection of pancreatic cancer using routine CT scans | — | Shanghai, Shanghai Municipality and 2 other locations | Recruiting | Oct 15, 2024 |
| Exploring biomarkers for early detection of pancreatic tumors | — | Hangzhou, Zhejiang | Recruiting | Jun 27, 2022 |
| Registry for pancreatic cysts at UCSF | — | San Francisco, California | Recruiting | Mar 2, 2020 |
All recruiting trials (7)
-
Blood protein biomarkers to help diagnose pancreatic cancer in adults
This study tests whether blood protein biomarkers can help detect pancreatic ductal adenocarcinoma and tell it apart from chronic pancreatitis and mucinous pancreatic lesions, and whether combining markers with CA 19-9 improves accuracy.
-
Liquid biopsy biomarkers to detect and monitor pancreatic cancer
Researchers test blood-based microRNA signals to see if they can identify pancreatic cancer risk or early disease in people with familial or hereditary risk or mucinous cysts.
-
Why surgery was performed for IPMN and the outcomes
This project looks at medical records of adults who had surgery for IPMN to see if operations were done for suspected cancer versus incidental findings and how those patients did afterward.
-
AI-enhanced low-dose CT to screen for pancreatic cancer
This project will test whether an AI tool called PANDA can read low-dose CT scans to find early pancreatic cancer in people aged 50 and older.
-
AI-based early detection of pancreatic cancer using routine CT scans
This study is testing an AI system that uses regular CT scans to see if it can help find pancreatic cancer early in people who are at high risk.
-
Exploring biomarkers for early detection of pancreatic tumors
This study is trying to find early warning signs in blood, urine, and other samples from patients with a specific type of pancreatic tumor to see if they can help predict when it might turn cancerous.
-
Registry for pancreatic cysts at UCSF
This study is setting up a registry to track patients with pancreatic cysts to see how these cysts change over time and to help doctors make better treatment decisions.
Related topics
Quick answers
How many Intraductal Papillary Mucinous Neoplasm clinical trials are recruiting right now?
7, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (4 trials), United States (2 trials), Italy (2 trials), Romania (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.